Amir Shabaka

1.5k total citations
37 papers, 418 citations indexed

About

Amir Shabaka is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Amir Shabaka has authored 37 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Amir Shabaka's work include Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (7 papers) and Nephrotoxicity and Medicinal Plants (4 papers). Amir Shabaka is often cited by papers focused on Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (7 papers) and Nephrotoxicity and Medicinal Plants (4 papers). Amir Shabaka collaborates with scholars based in Spain and Uruguay. Amir Shabaka's co-authors include Gema Fernández‐Juárez, Beatriz Sánchez‐Álamo, Victoria Cachofeiro, Fernando Caravaca‐Fontán, Manuel Praga, Luís F. Quintana, Alberto de Lorenzo, C. Galéano, Eva Rodríguez and Jesús Oliva and has published in prestigious journals such as Transplantation, Clinical Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Amir Shabaka

33 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Shabaka Spain 10 215 78 76 61 50 37 418
Honglang Xie China 11 253 1.2× 97 1.2× 61 0.8× 29 0.5× 49 1.0× 23 483
Kres̆imir Gales̃ić Croatia 12 209 1.0× 179 2.3× 47 0.6× 40 0.7× 48 1.0× 61 474
Tianjun Guan China 10 171 0.8× 58 0.7× 87 1.1× 22 0.4× 37 0.7× 33 367
Gonzalo P. Méndez Chile 11 97 0.5× 201 2.6× 194 2.6× 59 1.0× 100 2.0× 44 564
Go Kanzaki Japan 17 390 1.8× 179 2.3× 178 2.3× 40 0.7× 83 1.7× 61 742
R. Goucha Tunisia 10 123 0.6× 62 0.8× 52 0.7× 22 0.4× 90 1.8× 62 346
Daisuke Tsukui Japan 7 192 0.9× 53 0.7× 89 1.2× 21 0.3× 72 1.4× 20 367
Arvind Ponnusamy United Kingdom 9 199 0.9× 73 0.9× 67 0.9× 13 0.2× 40 0.8× 32 356
Nattawat Klomjit United States 11 227 1.1× 94 1.2× 105 1.4× 14 0.2× 113 2.3× 31 461
Ioannis Petrakis Greece 13 231 1.1× 67 0.9× 126 1.7× 11 0.2× 87 1.7× 43 506

Countries citing papers authored by Amir Shabaka

Since Specialization
Citations

This map shows the geographic impact of Amir Shabaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Shabaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Shabaka more than expected).

Fields of papers citing papers by Amir Shabaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Shabaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Shabaka. The network helps show where Amir Shabaka may publish in the future.

Co-authorship network of co-authors of Amir Shabaka

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Shabaka. A scholar is included among the top collaborators of Amir Shabaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Shabaka. Amir Shabaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shabaka, Amir, Sara Martínez‐Martínez, Isabel Galán, et al.. (2025). Lipidomics Unveils Critical Lipid Pathway Shifts in Alport Syndrome. Kidney International Reports. 10(8). 2805–2820.
2.
Sánchez‐Álamo, Beatriz, et al.. (2025). Acute Drug-Induced Tubulointerstitial Nephritis: Current Perspectives on Diagnosis and Treatment. PubMed. 32(4). 341–349.
3.
Torrá, Roser, Xoana Barros, Montserrat M. Díaz Encarnación, et al.. (2025). When should the nephrologist think about genetics in patients with glomerular diseases?. Clinical Kidney Journal. 18(3). sfaf044–sfaf044.
4.
5.
Shabaka, Amir, et al.. (2023). Efficacy and Safety of CT-Guided Kidney Biopsy for the Diagnosis of Glomerular Diseases in Complicated Patients. ˜The œNephron journals/Nephron journals. 148(1). 16–21. 2 indexed citations
6.
Trujillo, Hernando, Teresa Cavero, Fernando Caravaca‐Fontán, et al.. (2022). IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy. Kidney International Reports. 7(4). 831–840. 12 indexed citations
7.
Shabaka, Amir, et al.. (2022). Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients: Results After 1 Year of Follow-Up. Frontiers in Medicine. 9. 927546–927546. 6 indexed citations
8.
Rabasco, Cristina, María José Soler, Amir Shabaka, et al.. (2022). Anti-glomerular Basement Membrane Glomerulonephritis: A Study in Real Life. Frontiers in Medicine. 9. 889185–889185. 9 indexed citations
9.
Vergara, Ander, Néstor Toapanta, Andrés Villegas, et al.. (2021). The Impact of Age on Mortality in Chronic Haemodialysis Population with COVID-19. Journal of Clinical Medicine. 10(14). 3022–3022. 7 indexed citations
10.
Shabaka, Amir, et al.. (2021). Fracaso renal agudo y síndrome nefrótico secundario a glomerulosclerosis segmentaria y focal asociada a COVID-19. Nefrología. 42(6). 727–729. 3 indexed citations
11.
Shabaka, Amir, et al.. (2021). Concomitant Acute Tubular Necrosis and Acute Interstitial Nephritis Induced by Tipifarnib in a Patient with Squamous Cell Carcinoma of the Lung. The American Journal of the Medical Sciences. 362(1). 99–102. 3 indexed citations
12.
Sánchez‐Álamo, Beatriz, Amir Shabaka, Juan F. Navarro‐González, et al.. (2021). Urinary Dickkopf-3: a new biomarker for CKD progression and mortality. Nephrology Dialysis Transplantation. 36(12). 2199–2207. 18 indexed citations
13.
Galán, Isabel, Almudena Vega, Marián Goicoechea, et al.. (2020). Hypermagnesemia is Associated with All-Cause Mortality in Patients with Chronic Kidney Disease. 5(1). 2 indexed citations
14.
Shabaka, Amir, et al.. (2020). Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective. ˜The œNephron journals/Nephron journals. 144(9). 413–427. 80 indexed citations
15.
Shabaka, Amir, et al.. (2020). Fulminant Emphysematous Pyelonephritis by <b><i>Candida glabrata</i></b> in a Kidney Allograft. ˜The œNephron journals/Nephron journals. 144(6). 304–309. 12 indexed citations
16.
José, Ana Pérez de, Javier Carbayo, Teresa Bada-Bosch, et al.. (2019). Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study. Clinical Kidney Journal. 14(2). 586–592. 13 indexed citations
17.
Fernández‐Juárez, Gema, Fernando Caravaca‐Fontán, Luís F. Quintana, et al.. (2018). Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis. Clinical Journal of the American Society of Nephrology. 13(12). 1851–1858. 71 indexed citations
18.
Shabaka, Amir, et al.. (2017). De Novo IgA Nephropathy in a Renal Allograft. Experimental and Clinical Transplantation. 17(4). 550–553. 4 indexed citations
19.
Calvo, Marta, Isabel Pérez-Flores, Natalia Calvo, et al.. (2016). Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. Transplantation Proceedings. 48(9). 2956–2958. 6 indexed citations
20.
Pérez-Flores, Isabel, et al.. (2016). Surgical Complications in En Bloc Renal Transplantation. Transplantation Proceedings. 48(9). 2953–2955. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Honglang Xie Breakdown of academic impact, for papers by Kres̆imir Gales̃ić Breakdown of academic impact, for papers by Tianjun Guan Breakdown of academic impact, for papers by Gonzalo P. Méndez Breakdown of academic impact, for papers by Go Kanzaki Breakdown of academic impact, for papers by R. Goucha Breakdown of academic impact, for papers by Daisuke Tsukui Breakdown of academic impact, for papers by Arvind Ponnusamy Breakdown of academic impact, for papers by Nattawat Klomjit Breakdown of academic impact, for papers by Ioannis Petrakis
Rankless by CCL
2026